PharmaBoardroom

Filip Standaert – Managing Director Nordics, Johnson &…

Filip Standaert outlines the significance of the Nordic cluster to J&J’s medical device operations in Europe, how the affiliate responded to the…

Thomas D. Madden – CEO, Acuitas Therapeutics

Dr Thomas D. Madden, CEO and founder of Acuitas Therapeutics, shares the story behind their involvement in Pfizer and BioNTech’s COVID-19 vaccine,…

Spain: Grifols looks to Egypt; New Leadership Generation at…

The latest from Spanish pharma, including the wide swathe of COVID-19 syringes, vaccines, masks, and tests being produced in the country, Grifols’…

Nicolaus Kröger – President, European Society for Blood…

Professor Nicolaus Kröger, president of the European Society for Blood and Marrow Transplantation (EBMT) introduces the multi-stakeholder GoCART…

Growth, COVID-19 Response & Essential Medicines Industry…

Graeme Duncan, CEO of ADVANZ PHARMA, highlights how the specialty generics firm has revitalized its operations since 2018 both culturally and…

Japan’s Taiho Pharmaceutical: An Oral Chemotherapy Pioneer

Japanese pharma companies are already far lower-profile than their occidental counterparts but an even lesser-known player may be Taiho…

Top 10 PharmaBoardroom Interviews of 2020

2020 was a challenging year globally, but one in which the importance of the healthcare and life sciences sector was underlined like never before.…

PharmaBoardroom Most Read Interviews of 2020

The top 10 most-read interviews on PharmaBoardroom in 2020 represents the broad geographic scope we have had in the past year. From Mexico to Morocco…

Italy: Menarini CEO on Averting Future Health Crises; Alfasigma…

A roundup of some of the most important recent stories from Italian pharma, including an in-depth interview with Menarini CEO Elcin Barker Ergun, a…

Medigen’s Charles Chen on Cell Culture Vaccine Strategies

Charles Chen of Taiwanese firm Medigen Vaccines Biologics Corp (MVC) shares his career journey, the company’s COVID-19 vaccine strategy, and what…

US Pharma Innovation Factsheet 2020

In a recent article for PharmaBoardroom, Objective Capital's David Crean took a look at the state of US innovation today and its long term…

The Value Proposition of Generics & Biosimilars in the USA

AAM President Dan Leonard highlights the findings of the association’s most recent report and re-states the value proposition of generic and…

Tagged with M